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Sonic Hedgehog Dependent Phosphorylation by CK1a
and GRK2 Is Required for Ciliary Accumulation and
Activation of Smoothened
Yongbin Chen1, Noriaki Sasai2, Guoqiang Ma1, Tao Yue1, Jianhang Jia3, James Briscoe2, Jin Jiang1*
1 Department of Developmental Biology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America, 2 MRC-National Institute for
Medical Research, Mill Hill, London, United Kingdom, 3 Markey Cancer Center and Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington,
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Abstract
Hedgehog (Hh) signaling regulates embryonic development and adult tissue homeostasis through the GPCR-like protein
Smoothened (Smo), but how vertebrate Smo is activated remains poorly understood. In Drosophila, Hh dependent
phosphorylation activates Smo. Whether this is also the case in vertebrates is unclear, owing to the marked sequence
divergence between vertebrate and Drosophila Smo (dSmo) and the involvement of primary cilia in vertebrate Hh signaling.
Here we demonstrate that mammalian Smo (mSmo) is activated through multi-site phosphorylation of its carboxyl-terminal
tail by CK1a and GRK2. Phosphorylation of mSmo induces its active conformation and simultaneously promotes its ciliary
accumulation. We demonstrate that graded Hh signals induce increasing levels of mSmo phosphorylation that fine-tune its
ciliary localization, conformation, and activity. We show that mSmo phosphorylation is induced by its agonists and
oncogenic mutations but is blocked by its antagonist cyclopamine, and efficient mSmo phosphorylation depends on the
kinesin-II ciliary motor. Furthermore, we provide evidence that Hh signaling recruits CK1a to initiate mSmo phosphorylation,
and phosphorylation further increases the binding of CK1a and GRK2 to mSmo, forming a positive feedback loop that
amplifies and/or sustains mSmo phosphorylation. Hence, despite divergence in their primary sequences and their
subcellular trafficking, mSmo and dSmo employ analogous mechanisms for their activation.
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Smoothened (Smo) as the obligatory Hh signal transducer [2,3].
Ptc inhibits Smo substoichiometrically through a poorly defined
mechanism in the absence of Hh [7]. Binding of Hh to Ptc and the
Ihog/Cdo family of proteins alleviates Ptc inhibition of Smo [8–
14], leading to Smo activation and signal transduction. How Smo
is activated and how it transduces the Hh signal to regulate GliR
and GliA are still poorly understood.
In mammals, Hh signaling depends on the primary cilium, a
microtubule-based membrane protrusion found in almost all
mammalian cells [15]. Key components in the Hh pathway are
found in cilia and exhibit dynamic patterns depending on the Hh
signaling state. For example, in the absence of Hh, Ptc localizes to
cilia and prevents Smo from accumulating in the cilia; binding of
Hh to Ptc triggers reciprocal trafficking of Ptc and Smo, with Ptc
moving out of and Smo accumulating in the cilia [16,17]. Ciliary
accumulation of Smo correlates but is not sufficient for Hh
pathway activation [16–19]. Additional mechanisms, including
conformational change in Smo, are likely to be responsible for
Smo activation [20–22]. Indeed, fluorescence resonance energy
transfer (FRET) analysis indicates that both Drosophila and

Introduction
The Hh family of secreted proteins plays pivotal roles during
embryonic development and adult tissue homeostasis [1–3].
Aberrant Hh signaling contributes to numerous human disorders
including congenital diseases and cancers [4,5]. In a number of
developmental contexts, Hh functions as a morphogen that
specifies distinct cell fates in a concentration-dependent manner
[1,2]. For example, in vertebrate neural tube patterning, Shh
secreted by the notochord and floor pate forms a ventral to dorsal
concentration gradient that specifies distinct pools of neural
progenitor cells [6].
Hh exerts its biological function through a signaling cascade
that ultimately controls a balance between activator and repressor
forms of the Gli family of transcription factors [2]. In the absence
of Hh, Gli2 and Gli3 are processed into truncated repressor forms
(GliR). Hh signaling blocks Gli processing and converts full-length
Gli2/3 into activator forms (GliA). The reception system for the
Hh signal consists of a twelve-transmembrane protein Patched
(Ptc) as the Hh receptor and a seven-transmembrane protein
PLoS Biology | www.plosbiology.org
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activity. In addition, we provide evidence that Shh promotes Smo
phosphorylation by regulating the accessibility of Smo to its kinases.

Author Summary
Hedgehog (Hh) signaling governs embryonic development
and adult homeostasis in species ranging from Drosophila
to human, and its malfunction has been implicated in a
wide range of human disorders. Hh signal is received by
the twelve-transmembrane receptor Patched and transmitted intracellularly by the seven-transmembrane protein
Smoothened (Smo). How vertebrate Smo is activated in
order to transmit the Hh signal remains poorly understood.
Here we investigate the molecular mechanism of mammalian Smo (mSmo) activation and find it is similar to that
described for Drosophila Smo despite the marked
sequence divergence between them. We show that mSmo
is activated via phosphorylation at multiple sites by the
serine/threonine kinases CK1a and GRK2. We provide
evidence that Sonic hedgehog (Shh; the best studied of
the three mammalian pathway ligands) can regulate the
accessibility of mSmo to these kinases and that phosphorylation promotes the ciliary accumulation of this transmembrane protein in its active conformation. Moreover,
increasing concentrations of Shh induce a progressive
increase in mSmo phosphorylation that fine-tunes mSmo
activity. Thus, our results provide novel insights into the
biochemical mechanism of vertebrate Hh signal transduction and reveal a conserved mode of Smo activation.

Results
CK1a and GRK2 Promote Smo Phosphorylation and
Conformational Switch
A previous study revealed that CK1a siRNA blocked Shh
pathway activation in C3H10T1/2 cells [33]. To determine how
CK1a positively regulates Shh signaling, we tested whether CK1a
activates Smo. Coexpression of CK1a with Smo in NIH3T3 cells
activated a Gli-luciferase (Gli-luc) reporter gene, although the fold of
activation was less dramatic compared with Shh stimulation
(Figure 1A). In line with a previous finding [31], coexpression of
GRK2 with Smo also activated Gli-luc in NIH3T3 cells (Figure 1A).
Coexpression of CK1a and GRK2 with Smo had a slightly
stronger effect on Gli-luc expression than overexpression of each
kinase alone (Figure 1A). Overexpression of another GRK family
member (GRK5) with Smo activated the Gli-luc reporter gene
similarly to GRK2 (Figure 1A), indicating that overexpressed
GRK5 and GRK2 have a similar activity in the Shh pathway.
We also examined the effect of CK1a/GRK2 overexpression on
Gli-luc expression in the absence of exogenously expressed Smo.
Consistent with previous findings [31,33], overexpression of CK1a,
GRK2, or both only slightly increased the expression of Gli-luc
reporter gene (Figure S1G). Thus, CK1a/GRK2 overexpression
synergized with Smo overexpression to drive Shh pathway activation.
Our previous FRET analysis indicated that Shh induces a
conformational change in Smo from a closed to an open
conformation [22]. In the closed conformation, Smo exists as a
dimer/oligomer through an N-terminal interaction(s), which
results in high basal FRET between CFP and YFP fused to the
N-termini of two Smo molecules (FRETN); however, Smo C-tail
folds back and is in close proximity to the intracellular loops,
resulting in high intramolecular FRET between CFP inserted in
the second intracellular loop (L2) and YFP fused to the C-terminus
(FRETL2C) and low intermolecular FRET between CFP and YFP
fused to the C-termini of two Smo molecules (FRETC) (Figure 1B–
D) [22]. Shh induced a marked decrease in FRETL2C and a
concomitant increase in FRETC without affecting FRETN
(Figure 1B–D) [22], suggesting that Smo C-tails move away from
the intracellular loops and form dimers/oligomers. To determine
whether CK1a and GRK regulate Smo conformation, we carried
out FRET analysis using the Smo biosensors indicated in
Figure 1B–D. We found that overexpression of CK1a, GRK2,
or GRK5 resulted in a significant increase in FRETC (Figure 1B)
and a marked decrease in FRETL2C (Figure 1C). In contrast,
overexpression of these kinases did not cause a significant change
in FRETN (Figure 1D). These results suggest that excessive CK1a
and GRK2/5 kinase activities induce a conformational change in
Smo similar to that induced by Shh stimulation.
Having established that CK1a and GRK2 act upstream of Smo, we
then determined whether CK1a and GRK2 could promote Smo
phosphorylation using a Phos-tag gel that specifically retards
phosphorylated proteins [34]. We found that coexpression of CK1a,
GRK2, or both with a Myc-tagged Smo (Smo-Myc) resulted in a clear
mobility shift of Smo-Myc on Phos-tag PAGE that was abolished by
phosphatase treatment (Figure 1E, lanes 5–10), suggesting that CK1a
and GRK2 can promote Smo phosphorylation.

mammalian Smo proteins exist as constitutive dimers/oligomers,
but in the absence of Hh, Smo C-tails adopt a closed conformation
that prevents their association. Hh induces a conformational
switch in Smo, leading to dimerization/oligomerization of the Ctails [22]. The mechanisms underlying mammalian Smo ciliary
accumulation, conformational change, and activation are largely
unknown.
In Drosophila, Hh and Ptc reciprocally control Smo cell surface
accumulation and conformation through regulating Smo phosphorylation [22–25]. In response to Hh, Smo is phosphorylated by
protein kinase A (PKA) and casein kinase 1 (CK1) at multiple sites
in its C-tail, and these phosphorylation events activate Smo by
promoting its cell surface accumulation and active conformation
[22,25–27]. However, vertebrate Smo C-tails diverge significantly
from that of Drosophila Smo and do not contain the PKA/CK1
phosphorylation clusters found in Drosophila Smo C-tail [22]. In
addition, a systematic mutagenesis study did not reveal any Ser/
Thr residues as essential for mammalian Smo activation [28].
These and other observations led to a proposal that mammalian
Smo and Drosophila Smo are regulated by fundamentally distinct
mechanisms [28,29].
Several studies suggested that G protein coupled receptor kinase
2 (GRK2) positively regulates Shh signaling [30–32]. Metabolic
labeling experiments revealed that GRK2 is required for the basal
phosphorylation of an exogenously expressed Smo [30]. However,
it is not clear whether GRK2 directly phosphorylates Smo and
how GRK2 activates Shh signaling. In addition, direct evidence
for Hh-induced mammalian Smo phosphorylation is lacking. A
recent kinome siRNA screen identified CK1a as a positive
regulator for Shh signaling, but its mechanism of action remains
unknown [33].
In this study, we investigate the activation mechanism of
mammalian Smo (henceforth referred to simply as Smo). We
demonstrate that Smo is activated via multiple phosphorylation
events mediated by CK1a and GRK2 that induce its ciliary
accumulation and active conformation. We provide evidence
that graded Shh signals induce increasing levels of Smo phosphorylation that fine-tune Smo ciliary localization, conformation, and
PLoS Biology | www.plosbiology.org

CK1a and GRK2 Are Required for Shh-Induced Smo
Phosphorylation
We next determined whether Shh normally induces Smo
phosphorylation and whether it does so through CK1a and
2
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Figure 1. CK1a and GRK2 regulate Smo phosphorylation and conformation. (A) Gli-luciferase assay in NIH 3T3 cells transfected with Smo
and kinase expressing constructs and treated with or without Shh-conditioned medium. (B–D) FRET analysis in NIH 3T3 cells transfected with SmoCFPC/SmoYFPC (B), SmoCFPL2YFPC (C), or SmoCFPN/SmoYFPN (D) and treated with or without Shh-conditioned medium or cotransfected with
indicated kinase expressing constructs. Filled and open circles in the cartoons denote CFP and YFP, respectively. (E–F) Cell extracts were prepared
from NIH 3T3 cells transfected by indicated constructs and treated with or without indicated reagents, separated on SDS-PAGE gel containing 25 mM
Phos tag-conjugated acrylamide, followed by immunoblotting with an anti-Myc antibody. The inhibitors used are: CK1 inhibitor, CKI-7 (10 mM); GRK
inhibitor Heparin (HP, 1 mM). PP indicates l-phosphatase treatment. (G) Gli-luc assay in NIH 3T3 cells stably expressing shRNA targeting CK1a, GRK2,
or GRK5 and transfected with or without Smo and treated with or without Shh-conditioned medium. (H) Cell extracts were prepared from NIH 3T3
cells stably expressing shRNA targeting CK1a, GRK2, or GRK5 and transfected with Smo-Myc and treated with or without Shh-conditioned medium,
separated on the Phos tag-conjugated SDS-PAGE gel and immunoblotted with an anti-Myc antibody.
doi:10.1371/journal.pbio.1001083.g001

GRK2. Treating Smo-Myc transfected cells with a Shh-conditioned medium but not a control medium induced a marked
mobility shift of Smo-Myc that was abolished by phosphatase
treatment (Figure 1E, lanes 3–4). Importantly, Shh-induced SmoMyc mobility shift was greatly reduced by treating cells with a
CK1 inhibitor CKI-7 [35] and/or a GRK inhibitor heparin [36]
(Figure 1F), suggesting that Shh induces Smo phosphorylation
through CK1 and GRK kinase activities.
To establish that CK1a and GRK2 are required for Shhinduced Smo phosphorylation, we generated cell lines stably
expressing shRNA targeting CK1a, GRK2, or GRK5. Two
independent shRNA constructs that effectively and selectively
knocked down the targeted kinase were employed in our assay
(Figure S1A–B). In line with previous findings [31–33], CK1a or
GRK2 shRNA inhibited Shh pathway activity in the Gli-luc
reporter assay (Figure 1G, Figure S1C–D, H). In contrast, GRK5
shRNA did not alter Shh-induced Gli-luc expression (Figure 1G,
Figure S1E). Importantly, CK1a and/or GRK2 shRNA but not
GRK5 shRNA reduced Shh-induced mobility shift of Smo-Myc
(Figure 1H, Figure S1F), suggesting that CK1a and GRK2 are
required for Shh-induced Smo phosphorylation. We note that
Shh-induced Smo mobility shift was not completely abolished by
silencing CK1a and GRK2, likely due to an incomplete
PLoS Biology | www.plosbiology.org

elimination of these kinase activities by the RNAi approach
(Figure S1B). However, it is also possible that the residual SmoMyc phosphorylation in the presence of CK1a and GRK2 shRNA
could be due to the involvement of another kinase(s).

CK1 and GRK Phosphorylate Smo C-tail at Multiple Sites
To determine whether CK1 and GRK directly phosphorylate
Smo, we developed an in vitro kinase assay in which purified
GST-fusion proteins containing different regions of Smo C-tail
were incubated with a recombinant CK1 (CK1d from New
England Biolabs) or GRK (GRK5 from Cell Signaling Technology) in the presence of c32-p-ATP. Two non-overlapping
fragments, amino acid (aa) 608–670 and aa 770–793, were
phosphorylated by both CK1 and GRK (Figure 2A, lanes 3, 5;
Figure 2B, lanes 3, 5), suggesting that they harbor CK1 and GRK
sites. GRK family kinases tend to phosphorylate S/T in an acidic
environment [37]. aa 608–670 contains three sequences (EPS615ADVS619S620A, QDVS642VT, and EIS666PELE) and aa 770–
793 contains one sequence (DADS791DF) that match GRK
consensus sites (Figure 2C). Indeed, mutating S615, S619 and S620
(SA1), S642 (SA2), or S666 (SA3) reduced and their combined
mutations (SA123) abolished phosphorylation of aa 608–670
(Figure 2B, lanes 8–12; Figure S2A and S2C, lanes 3–9), whereas
3
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Figure 2. CK1 and GRK phosphorylate multiple sites in Smo C-tail. (A–B) In vitro kinase assay using a recombinant CK1d or GRK5 and purified
GST-fusion proteins carrying indicated Smo fragments. (C) A schematic drawing of a full-length Smo with the sequences of the six CK1/GRK
phosphorylation sites shown underneath (S0–S5) and color coded: blue for CK1 specific sites; red for GRK specific sites; green for sites phosphorylated
by both CK1 and GRK. Smo variants with the indicated substitutions are listed. Sequence alignment shows that the CK1/GRK phosphorylation sites
are highly conserved among Mouse (m), Human (h), Chick (g), and Zebrafish (z) Smo proteins. (D) Cell extracts were prepared from NIH 3T3 cells
transfected with Smo-Myc or SmoSA0–5-Myc and with or without cotransfection of the indicated kinase expressing constructs and treated with or
without Shh-conditioned medium. The extracts were separated on Phos tag-conjugated SDS-PGAE gel and immunoblotted with an anti-Myc
antibody. PP indicates l-phosphatase treatment. (E) Cell extracts were prepared from NIH 3T3 cells transfected with Smo-Myc and with or without
indicated kinase expressing constructs, followed by treating with or without Shh-conditioned medium or indicated kinase inhibitors. The extracts
were subjected to SDS-PAGE, followed by immunoblotting with the PS1 antibody. The membrane was stripped and probed with Myc antibody for
Smo-Myc. (F) Cell extracts prepared from shRNA lines targeting CK1a, GRK2, or GRK5 transfected by Smo-Myc and treated with or without Shhconditioned medium were analyzed as in (E). (G) NIH 3T3 cells were transiently transfected with Smo-Myc and treated without or with increasing
levels of ShhN peptides (1 nM, 2 nM, 5 nM). 8XGliBS-luc activities were normalized by control pRL-TK. Cell extracts were separated on Phos tagconjugated (top panel) or regular SDS-PAGE gel (bottom two panels), followed by immunoblotting with Myc or PS1 antibody. (H–I) Cell extracts from
NIH 3T3 cells transfected with the indicated constructs and treated with or without Shh-conditioned medium, CYC (cyclopamine; 10 mM), SAG
(200 nM), or 20-OHC (20a-hydroxycholesterol; 10 mM) were separated on SDS-PAGE gel and probed with PS1 antibodies. The membranes were
stripped and probed with Myc antibody to monitor Smo-Myc levels.
doi:10.1371/journal.pbio.1001083.g002

whereas S774, S777, and S791 mediated CK1 phosphorylation of aa
770–793 (Figure 2A, lanes 14–16). aa 608–670SA1, which has
S615, S619, and S620 mutated to Ala but contains intact S642 and
S666, was not phosphorylated by CK1 (Figure 2A, lane 8),
suggesting that S642 and S666 are not CK1 sites. In addition, we
found that aa 581–612 was phosphorylated by CK1 but not by
GRK (Figure 2A, lane 18; unpublished data). This region contains

mutating S791 abolished phosphorylation of aa 770–793 by GRK
(Figure 2B, lane 14), suggesting that these Ser residues are GRK
sites.
CK1 phosphorylation sites conform to the consensus: D/E/S/
T(P)X1–3S/T [38]. Site-directed mutagenesis revealed that S615,
S619, and S620 mediated CK1 phosphorylation of aa 608–670
(Figure 2A, lanes 8–12; Figure S2A and Figure S2B, lanes 3–9),

PLoS Biology | www.plosbiology.org

4

June 2011 | Volume 9 | Issue 6 | e1001083

Mechanism of Smoothened Activation

by the S1–5 mutation (A1SA1–5) (Figure 2H, lanes 7–8; Figure
S2H), suggesting that the oncogenic mutation mimics Shh
stimulation to induce Smo phosphorylation at CK1/GRK sites.
We also observed that M1 increased Smo phosphorylation (see
below).
Previous studies demonstrated that small molecules including
SAG and 20a-hydroxycholesterol (20-OHC) promote whereas
cyclopamine blocks Smo activation [20,21,40,41]. We found that
SAG and 20-OHC induced whereas cyclopamine blocked Smo
phosphorylation at CK1/GRK sites (Figure 2I), suggesting that
these small molecules regulate Shh signaling at the level of Smo
phosphorylation.

a sequence matching CK1 consensus sites: ELS592FS594MHT597
VS599. Indeed, mutating S592, S594, T597, and S599 to Ala (aa 581–
612SA0) abolished CK1 phosphorylation of aa 581–612
(Figure 2A, lane 19).
For simplicity, we referred to S592, S594, T597, and S599
collectively as S0; S615, S619, and S620 as S1; S642 as S2; S666 as S3;
S774 and S777 as S4; and S791 as S5 (Figure 2C). Thus, S1 and S5
are phosphorylation sites for both CK1 and GRK, whereas S0/S4
and S2/S3 are selectively phosphorylated by CK1 and GRK,
respectively. Sequence alignment indicates that these phosphorylation sites are conserved among vertebrate Smo proteins
(Figure 2C).
To determine if the CK1/GRK sites identified in vitro mediate
Shh-induced Smo phosphorylation in vivo, we mutated S0–S5 to
Ala in Smo-Myc (SA0–5, Figure 2C). We found that the SA0–5
mutation abolished Shh, CK1a, or GRK2-induced Smo mobility
shift (Figure 2D, lanes 5–12). Furthermore, CK1a and GRK2
neither activated SA0–5 nor induced its conformational change
(Figure S2D–E).
To further characterize Smo phosphorylation in vivo, we
attempted to generate phospho-specific antibodies against phosphorylated CK1/GRK sites and succeeded in obtaining an
antibody (PS1) that specifically recognizes phosphorylated S1
(pS615, pS619, and pS620, Figure S2F). To monitor phosphorylation
at S1, NIH3T3 cells were transfected with Smo-Myc and
stimulated with or without Shh-conditioned medium. In the
absence of Shh, Smo-Myc exhibited a weak PS1 signal likely due
to basal phosphorylation (Figure 2E, lane 1). Shh induced a clear
increase in the intensity of the PS1 signal (Figure 2E, lane 3).
Coexpression of CK1a, GRK2, or both also increased the PS1
signal (Figure 2E, lanes 5, 7, and 9). On the other hand, Shhstimulated S1 phosphorylation was diminished by treating cells
with the CK1 and/or GRK2 kinase inhibitors (Figure 2E, lanes
11–13). Furthermore, CK1a or GRK2 shRNA reduced whereas
combined CK1a/GRK2 shRNA nearly abolished S1 phosphorylation (Figure 2F, lanes 4, 6, and 8; Figure S2G). In contrast,
GRK5 shRNA did not affect S1 phosphorylation (Figure 2F, lane
10; Figure S2G), consistent with its lack of effect on Shh pathway
activity. These results demonstrate that Shh induces S1 phosphorylation by CK1a and GRK2.

CK1/GRK Phosphorylation Sites Are Essential for Smo
Activation
To determine the functional significance of Smo phosphorylation, CK1/GRK sites were mutated to Ala individually or in
different combinations (referred to as SA mutation; Figure 2C),
and the effect of SA mutations on Smo activity was determined by
the Gli-luc reporter assay in smo2/2 MEFs. Mutating S0 (SA0) or
S1 (SA1) slightly reduced whereas their combined mutations (S01)
markedly inhibited Shh-induced Smo activity (Figure 3A). While
mutating S2 to S5 either individually (SA2, SA3, SA5) or in
combinations (SA23, SA45) had little if any effect on Smo
activation (Figure 3A), combined mutations of these sites with S1/
S0 (SA12, SA13, SA123, SA0–3, SA1–5, SA0–5) resulted in a
progressive decrease in Shh-induced Smo activity (Figure 3A).
Finally, simultaneously mutating all CK1/GRK sites (SA0–5)
completely abolished Shh-induced Smo activation. These results
suggest: 1) phosphorylation at CK1/GRK sites is essential for Smo
activation; 2) S0 and S1 are the major sites while S2 to S5 may
play a fine-tuning role; and 3) the level of Smo activity correlates
with its level of phosphorylation.
To determine whether phosphorylation renders constitutive
Smo activity, we converted individual or different combinations of
CK1/GRK sites to Asp (referred to as SD mutations) to mimic
different levels of phosphorylation (Figure 2C). SD mutations of
individual sites (SD0, SD1, SD2, SD3) or several combinations
(SD23, SD12, SD13) caused little if any increase in the basal
activity of Smo (Figure 3B); however, other combinations (SD01,
SD123, SD0–3, SD1–5, SD0–5) resulted in a clear elevation of
Smo basal activity and the level of basal activity correlates with the
number of altered sites (Figure 3B). Nevertheless, the constitutive
activities of SmoSD variants are lower compared with that of
SmoA1 (Figure 3B). Furthermore, the SD variants were further
stimulated by Shh, whereas SmoA1 was no longer regulated by
Shh (Figure 3B). Thus, phosphorylation at CK1/GRK sites
increases Smo activity in a dose dependent manner but does not
confer full activation.
To determine whether the oncogenic mutation activates Smo
through its phosphorylation, we mutated several CK1/GRK sites
to Ala in SmoA1. Mutating S2/3 (A1SA2, A1SA3, A1SA23) had
little if any effect on SmoA1 activity (Figure 3C). In contrast, S1
mutation (A1SA1) or combined mutations of S1 with other sites
(A1SA12, A1SA13, A1SA123, A1SA1–5) greatly reduced or
nearly abolished SmoA1 activity (Figure 3C), suggesting that S1
phosphorylation is critical for the oncogenic mutation to activate
Smo. Of note, the SA1 mutation had a more profound effect on
the activity of SmoA1 than that of wild type Smo in the presence
of Shh (compare SmoA1SA1 with SmoSA1+Shh). The reason for
this difference is unclear, but it is possible that the oncogenic
mutation may not fully mimic Shh stimulation so that SmoA1
relies on S1 phosphorylation for its activation more than wild type
Smo.

Regulation of Smo Phosphorylation by Graded Shh
Signals, Oncogenic Mutations, and Small Molecules
Hh signaling strength depends on the level of Hh ligand [2]. To
determine if the level of Shh pathway activity correlates with the
level of Smo phosphorylation, NIH3T3 cells transfected with SmoMyc were treated with different levels of Shh, followed by mobility
shift assay on the phospho-tag gel or western blot with PS1. We
found that increasing levels of Shh induced a progressive increase
in the degree of Smo-Myc mobility shift (Figure 2G), suggesting
that Smo-Myc was phosphorylated at more sites in response to
higher levels of Shh. In addition, we found that increasing levels of
Shh resulted in a gradual increase in the PS1 signal (Figure 2G),
suggesting that the frequency of S1 phosphorylation increases with
increasing Shh concentration.
Several oncogenic mutations in human Smo have been
identified, including M1 and M2 [39]. The M2 mutation occurs
in the seventh transmembrane domain whose murine counterpart
is the A1 mutation [20,39]. Previous studies suggest that SmoA1
exhibits constitutive activity, accumulates at primary cilia, and
adopts an open conformation [16,20,22]. We found that SmoA1
exhibited slower mobility and elevated PS1 signal intensity
regardless of Shh treatment (Figure 2H, lanes 4–5; Figure S2H)
and that A1-induced PS1 signal and mobility shift were abolished
PLoS Biology | www.plosbiology.org
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Figure 3. Phosphorylation at multiple CK1 and GRK sites regulates Smo activity both in vitro and in vivo. (A–C) Gli-luc activity assays for
smo2/2 MEFs transfected with the indicated Smo expressing constructs together with the 8XGliBS-luc reporter gene and a control pRL-TK. The cells
were treated with or without Shh-conditioned medium 2 d after transfection. (D–E) HH st11–12 chick neural tubes were electroporated with the
indicated expression constructs and assayed by immunohistochemistry 48 h after transfection. (D) The expression of Pax7, Islet1/2, Olig2, and Nkx2.2
in anterior thoracic regions of embryos transfected with wild-type Smo (SmoWT), SmoSD123, SmoA1, or SmoA1SA1–5. Cells expressing the
constructs were identified by CFP (green). Arrows indicate the expanded expression of Islet1/2, Olig2, and Nkx2.2 and the reduction of Pax7
expression. SmoA1 exhibited potent constitutive activity, leading to the repression of Pax7 and induction of ectopic Islet1/2, Olig2, and Nkx2.2.
Mutating multiple CK1/GRK sites in SmoA1 (A1SA1–5) diminished its constitutive activity. SmoSD123 also exhibited constitutive activity, resulting in a
reduction of Pax7 expression and expansion of Islet1/2, Olig2, and Nkx2.2, albeit less dramatic than SmoA1. Note that there was also a subtle
expansion of Olig2 in some embryos transfected with SmoWT. (E) Embryos co-transfected at a ratio of 2:1 with Ptc1Dloop2 (PtcD2) and either Smo-WT,
SmoSD0–5, or SmoA1 and assayed for Pax7, Islet1/2, Olig2, and Nkx2.2 expression. Ptc1Dloop2 inhibits Shh signaling resulting in the repression of
Islet1/2, Olig2, and Nkx2.2, and a ventral expansion of Pax7. SmoSD123 and SmoSD0–5 but not SmoWT overcame the dominant inhibitory effect of
Ptc1Dloop2.
doi:10.1371/journal.pbio.1001083.g003

We also found that mutating SA0–5 abrogated SAG-induced
Smo activation, whereas SD0–5 exhibited resistance to cyclopamine inhibition (Figure S2I), suggesting that SAG and cyclopamine regulate Smo activity by influencing its phosphorylation.

however, electroporation of Smo variants that mimic high-level
phosphorylation (SD123, SD1–5, SD0–5) resulted in a dorsal
expansion of several ventral markers, including Nkx2.2, Olig2,
Nkx6.1, and Islet1 (Figure 3D and Figure S3D). Furthermore,
SD123 and SD0–5 but not SmoWT restored the expression of
ventral markers suppressed by a dominant form of Ptc, Ptc1Dloop2
(PtcD2), as well as prevented the derepression of the dorsal marker
Pax7 (Figure 3E) [42]. These results suggest that phosphorylation
at CK1/GRK sites increased the basal activity of Smo in the chick
neural tubes.
In line with tissue culture experiments, SmoA1 is more potent
than SmoSD variants in inducing ectopic expression of ventral
marker genes in chick neural tubes (Figure 3D, Figure S3B).
Mutating S1 (A1SA1) or combination of S1 with other sites to Ala
(A1SA12, A1SA13, A1SA123, A1SA1–5) diminished or complete-

Mutating CK1/GRK Sites Affects Smo Activity In Vivo
We next used chick neural tubes to determine the role of Smo
phosphorylation in Shh signaling in living organisms. CFP-tagged
constructs expressing wild type (WT) or mutant forms of Smo were
electroporated into one side of the neural tube, leaving the other
side as an internal control, followed by immunostaining to
visualize the expression of various Hh responsive genes. Electroporation of SmoWT or Smo variants that mimic low-level
phosphorylation (SD1, SD12) did not significantly alter the
expression of the marker genes (Figure 3D and Figure S3A);
PLoS Biology | www.plosbiology.org
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A recent study suggested that b-arrestins mediate Smo ciliary
localization by binding to Smo and facilitating its interaction with
the kinesin-II motor [43]. We hypothesized that Shh-induced Smo
phosphorylation promotes its ciliary localization by recruiting barrestins. To test this possibility, we transfected NIH 3T3 cells with
a YFP-tagged b-arrestin2 (b-arr2-YFP) together with Myc-tagged
wild type or mutant forms of Smo. As shown in Figure 4, both Shh
and the A1 mutation increased the amount of b-arr2 coimmunoprecipitated with Smo (Figure 4C, lanes 2, 7). The SA mutations
nearly abolished Shh- or A1-stimulated interaction (Figure 4C,
lanes 4,10), whereas SD0–5 promoted Smo/b-arr2 interaction
(Figure 4C, lane 5).
We also confirmed that phosphorylation regulates Smo/b-arr2
association using FRET assay. We found that Shh and A1
increased the FRET between Smo-CFP and b-arr2-YFP, and this
increase was abolished by the SA0–5 mutation (Figure 4D).
Conversely, SD0–5 increased the basal FRET between Smo-CFP
and b-arr2-YFP. Thus, Shh-induced phosphorylation at CK1/
GRK sites increases the association between Smo and b-arr2,
which may account for the increased ciliary localization of Smo.

ly abolished A1-mediated ectopic activation of ventral markers or
suppression of Pax7, whereas mutating S2 and 3 (A1S23) had little
if any effect on SmoA1 activity (Figure 3D, Figure S3B), suggesting
that phosphorylation at S1 is critical for the oncogenic mutation to
activate Smo in the chick neural tube.

Phosphorylation of Smo Promotes Its Ciliary
Accumulation
Shh induces ciliary accumulation of Smo that correlates with
pathway activation, but the underlying mechanism is poorly
understood [16,17]. We determined whether Shh promotes Smo
ciliary localization by inducing its phosphorylation at CK1/
GRK sites by examining ciliary localization of CFP-tagged wild
type or phosphorylation site mutant forms of Smo in MEF cells
treated with or without Shh-conditioned medium. As overexpression by transient transfection caused high basal ciliary
localization of Smo, we used retroviral infection to express low
levels of exogenous Smo. In these conditions, SmoWT was found
in less than 5% of cilia in the absence of Shh but accumulated in
,70% of cilia in response to Shh treatment (Figure 4A–B). We
found that SA mutations inhibited Shh-induced whereas SD
mutations promoted basal ciliary accumulation of Smo in a dosedependent manner (Figure 4A–B). In addition, constitutive
ciliary localization of SmoA1 was inhibited by the SA1–5
mutation (A1SA1–5, Figure 4A–B). Thus, phosphorylation at
CK1/GRK sites is both necessary and sufficient for the ciliary
localization of Smo.

Phosphorylation Promotes an Open Conformation of
Smo
To determine whether phosphorylation at CK1/GRK sites
regulates Smo conformation, we mutated individual or combination of CK1/GRK sites to either Ala or Asp in C-terminally CFP/
YFP-tagged Smo and carried out FRET analysis in NIH3T3 cells.

Figure 4. Regulation of Smo ciliary localization by CKI/GRK-mediated phosphorylation. (A–B) Wild-type MEFs infected with retrovirus
encoding CFP-tagged wild-type Smo or indicated Smo variants and treated with or without Shh-conditioned medium were immunostained to show
the expression of Acetylated (Ac)-tubulin (Red) that labels the primary cilium, GFP (green) that labels the CFP-tagged Smo proteins, and DRAQ5 (blue)
that labels the nucleus (A). The insets show enlarged views of the selected regions with shifted overlays. Quantification of ciliary localization of
infected Smo variants as indicated by the percentage of GFP+ cilia is shown in (B). Over 100 ciliated cells were counted for each Smo construct. (C)
Shh promotes the interaction between Smo with b-arr2. NIH 3T3 cells were transfected with the indicated Myc-tagged Smo variants and YFP tagged
b-arr2. Cells lysates were subjected to western blot analysis with Myc and GFP antibodies or immunoprecipitated with the Myc antibody, followed by
western blot analysis with the GFP antibody. Asterisk indicates IgG heavy chain. (D) FRET analysis of NIH 3T3 cells transfected with indicated Cterminally CFP-tagged Smo variants and C-terminally YFP-tagged b-arr2 and treated with or without Shh-conditioned medium.
doi:10.1371/journal.pbio.1001083.g004
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Figure 5. Shh, A1, SAG, and cyclopamine regulate Smo conformation through CK1/GRK-mediated phosphorylation. (A–C) FRET
analyses of NIH 3T3 cells transfected with C-terminally CFP/YFP-tagged wild type Smo or Smo variants with the indicated mutations and treated with
or without Shh-conditioned medium (mean 6 s.d., n$10). (D) FRET analysis in NIH 3T3 cells transfected with Smo-CFPC/YFPC, SmoSA0–5-CFPC/YFPC,
or SmoSD0–5-CFPC/YFPC, and treated without or with Shh-conditioned medium, 200 nM SAG, or a combination of Shh-conditioned medium and
10 mM cyclopamine (mean 6 s.d., n$10).
doi:10.1371/journal.pbio.1001083.g005

SA0 or SA1 slightly reduced Shh-induced FRETC, whereas
individual mutations at other sites (SA2, SA3, SA5) had no effect
(Figure 5A). S0 and S1 double mutation (S01) or combined
mutation of S0/1with other sites (SA12, SA13, SA123, SA1–5,
SA0–5) greatly reduced or nearly abolished Shh-induced FRETC
(Figure 5A). On the other hand, the SD mutations resulted in a
dose-dependent increase in the basal FRETC (Figure 5B). Overall,
the effects of SA or SD mutations on Shh-induced FRETC
correlated with their effects on Shh-induced Smo activation.
The SA mutations also diminished A1-induced FRETC
(Figure 5C). Furthermore, SA0–5 abolished SAG-induced
FRETC, whereas SD0–5 conferred high basal FRETC even in
the presence of cyclopamine (Figure 5D). Thus, phosphorylation at
CK1/GRK sites induced by Shh, A1, and SAG causes a
conformational switch in Smo C-tail, leading to its dimerization,
whereas cyclopamine locks Smo in the closed conformation by
blocking its phosphorylation.

(NIH3T3Smo-CFP). NIH3T3Smo-CFP did not exhibit significant
basal ciliary localization of Smo-CFP or ciliary PS1 signal but
accumulated both signals in the cilia upon stimulation with Shh,
SAG, or 20-OHC (Figure 6A, Figure S4A). Cyclopamine induced
ciliary accumulation of Smo-CFP but not PS1 (Figure 6A, Figure
S4A). Furthermore, cyclopamine blocked Shh or 20-OHC but
not SAG-induced ciliary PS1 signals (Figure 6A; Figure S4A).
Thus, Shh, SAG, and 20-OHC induced ciliary accumulation of
phosphorylated Smo, whereas cyclopamine trapped unphosphorylated Smo in the cilia. The difference in the sensitivity of
SAG and 20-OHC to cyclopamine could be due to different
mechanisms of action employed by these small molecules to
regulate Smo.
To examine the dynamics of Smo phosphorylation, we treated
NIH3T3SmoCFP cells with Shh-conditioned medium or SAG for
different periods of time (1, 2, 4, and 24 h). In line with a previous
report [17], both Shh and SAG induced a rapid ciliary
accumulation of Smo-CFP, and the percentage of Smo-CFP
positive cilia as well as the mean intensity of SmoCFP signal
increased over time (Figure 6B–D). Importantly, we observed a
similar kinetics for PS1 accumulation in the primary cilia
(Figure 6B–D). Furthermore, the ratio of PS1 versus Smo-CFP
signal intensity in primary cilia remained relatively constant over
time.

Smo Phosphorylation at the Primary Cilium
To examine the spatial and temporal regulation of Smo
phosphorylation, we carried out immunohistochemistry experiments using the PS1 antibody that recognizes phosphorylated S1.
Because PS1 failed to detect endogenous Smo, we generated
NIH3T3 cells stably expressing low levels of Smo-CFP
PLoS Biology | www.plosbiology.org

8

June 2011 | Volume 9 | Issue 6 | e1001083

Mechanism of Smoothened Activation

Figure 6. Smo phosphorylation at the primary cilium. (A) NIH 3T3 cells stably expressing Smo-CFP were either untreated (control) or treated
with Shh-conditioned medium (Shh), SAG (200 nM), 20-OHC (10 mM), CYC (10 mM), or a combination of Shh-conditioned medium and CYC (10 mM).
Cells were immunostained to show the expression of acetylated tubulin (red; primary cilium), GFP (green; Smo), and PS1 (phosphorylated Smo; blue).
Images in the insets are shifted overlays of the selected fields. (B–C) The percentage of Smo-CFP (GFP) or phosphorylated Smo (PS1) positive primary
cilia at different time after cells were treated with or without Shh or SAG (200 nM). Over 100 ciliated cells were counted for each time point, n = 3. (D)
NIH 3T3Smo-CFP cells were treated with 200 nM SAG for 1, 2, 4, or 24 h, followed by immunostaining to show the expression of acetylated tubulin
(red), GFP (green), and PS1 (blue). Representative images with shifted overlay were shown for each time point. Histograms underneath show the
relative intensities of PS1 or GFP fluorescence signals and their ratios (PS1/CFP) at each time point. The ratios are normalized to that of 24 h time
point, which is set at 100%. (E) NIH 3T3Smo-CFP cells were treated with Shh-conditioned medium for 0, 1, 2, 4, or 24 h. Cell extracts at each time point
were separated on SDS-PAGE and probed with the indicated antibodies. Histograms show the relative intensities of PS1 and GFP bands quantified by
the ImageJ software and their ratio (PS1/CFP) normalized to that at 24 h. (F) Cell extracts prepared from NIH 3T3 cells transfected with the indicated
constructs and treated with or without Shh-conditioned medium were subjected to western blot analysis with the indicated antibodies.
doi:10.1371/journal.pbio.1001083.g006

induced FRETC was dramatically reduced in Kif3a2/2 MEFs
compared with WT MEFs (Figure S4B). In contrast, SmoSD0–5CFPC/YFPC exhibited high FRETC in both WT and Kif3a2/2
MEFs (Figure S4B). Thus, in the absence of primary cilia, Shh and
A1 failed to induce the active Smo conformation because of
compromised Smo phosphorylation, but an open conformation
can be restored by phospho-mimetic mutations.
Although SmoSD0–5 adopts an open conformation in Kif3a2/2
MEFs, it failed to induce any Gli-luc expression in the absence of
primary cilia (Figure S4C). In contrast, overexpression of Gli1 in
Kif3a2/2 MEFs activated the Gli-luc reporter. These observations
suggest that the primary cilium is not only required for Smo
activation but is also essential for signal transduction downstream of
activated Smo.

We also monitored Smo phosphorylation in whole cells by
western blot using the PS1 and GFP antibodies. We found that the
ratio of PS1 versus Smo-CFP signal intensity was lower at early
time points and gradually increased over time (Figure 6E). Thus,
Smo phosphorylation exhibited faster kinetics in primary cilia than
in whole cells, implying that Smo could be preferentially
phosphorylated near or in the primary cilia in response to Shh
or SAG, leading to its rapid accumulation in the cilia.

Efficient Smo Phosphorylation Depends on the Kinesin-II
Ciliary Motor
To investigate whether primary cilia regulate Smo phosphorylation, we disrupted the cilia using a dominant negative form of
Kif3b (DN-Kif3b), a subunit of the kinesin-II motor required for
cilia formation [44]. We found that DN-Kif3b diminished but did
not completely block Shh-induced PS1 signal associated with
either Smo-Myc or SmoA1-Myc (Figure 6F, lanes 3, 6), suggesting
that efficient phosphorylation at S1 depends on the kinesin-II
ciliary motor.
We also analyzed whether the primary cilium is required for
Shh-induced Smo conformational change by measuring FRETC
in the wild type or Kif3a2/2 MEFs transfected with wild type or
mutant forms of Smo-CFPC/YFPC. We found that Shh or A1PLoS Biology | www.plosbiology.org

Shh Promotes Binding of CK1a and GRK2 to Smo
Finally, we investigated how Shh induces Smo phosphorylation
by testing the possibility that Shh promotes the accessibility of Smo
to its kinases. By immunoprecipitation assay, we found that Shh
markedly increased the association between Smo-Myc and
endogenous CK1a and GRK2 in NIH3T3 cells (Figure 7B, lanes
1–2; Figure 7C). In addition, Shh induced accumulation of CK1a
in primary cilia (Figure 7D). The binding of CK1a/GRK2 to
9
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Figure 7. Shh promotes CK1a/GRK2 binding to Smo. (A) Schematic drawings of full-length and truncated Smo with point mutations indicated
by the asterisks. Black boxes denote the transmembrane domains. L430A is located in the third intracellular loop; A1 in the seventh transmembrane
domain; M1, S570A, and I573A are located in the membrane proximal region of the Smo C-tail. (B–C, E–H) Coimmunoprecipitation assays to
determine the interaction between CK1a/GRK2 with different forms of Smo. NIH 3T3 cells were transfected with the indicated Myc-tagged or HAtagged Smo constructs, followed by immunoprecipitation and western blot analysis with indicated antibodies. Cell lysates were also directly
immunoblotted by the indicated antibodies. Histogram in (C) shows the quantification of (B) with CK1a binding normalized by the Smo input and
compared with lane 1. *p,0.05, **p,0.01, ***p,0.005. Western blots were quantified using the ImageJ software followed by Prism analysis, n = 3.
Quantifications of (G) and (H) are shown in Figure S5. (D) NIH 3T3 cells untreated (control) or treated with Shh-conditioned medium were
immunostained to show the expression of acetylated tubulin (red), CK1a (green), and DRAQ5 (blue). Images in the insets are shifted overlays of the
selected fields. (I) NIH 3T3 cells were transfected with the indicated Myc-tagged Smo constructs either alone or together with a Flag-tagged CK1a
construct and treated with or without Shh-conditioned medium, followed by immunoprecipitation and western blot analysis with the indicated
antibodies. Cell lysates were also directly immunoblotted by the indicated antibodies. (J) A model for how Smo phosphorylation is regulated by Shh.
See text for details.
doi:10.1371/journal.pbio.1001083.g007
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Smo-Myc is specific because we did not detect association between
Smo-Myc and endogenous CK1e or GRK5 under the same
condition (unpublished data).
To further explore the interactions between Smo and CK1a/
GRK2 and their regulation, we generated several N- or Cterminally truncated forms of Smo (Figure 7A). As shown in
Figure 7E, CK1a and GRK2 coimmunoprecipitated with HAtagged Smo C-tail from aa 544 to aa 793 (SmoCT). Deletion of aa
544–565 from the Smo C-tail (SmoCT2) did not affect CK1a/
GRK2 binding; however, further deletion of aa 565–588
(SmoCT3) abolished CK1a binding but did not affect GRK2
binding, suggesting that the membrane proximal region of Smo Ctail between aa 565 and 588 mediates CK1a binding, whereas the
distal region between aa 588 and 793 binds GRK2. Consistent
with this, we found that SmoDC588 but not SmoDC565 pulled
down CK1a and neither SmoDC565 nor SmoDC588 pulled down
GRK2 (Figure 7G, lanes 3–6). Thus, the CK1a binding pocket is
located N-terminal to the phosphorylation sites.
Interestingly, SmoDC588 exhibited increased basal binding to
CK1a (Figure 7G, compare lanes 1 and 5), suggesting that the
distal region of Smo C-tail inhibits CK1a binding in the absence of
Shh. We hypothesized that unphosphorylated Smo C-tail adopts a
closed conformation that could mask the membrane proximal
CK1a binding domain (Figure 7J). Indeed, the SA0–5 mutation,
which locked Smo C-tail in its closed conformation, diminished
Shh-stimulated CK1a binding, whereas the SD0–5 mutation,
which locked the Smo C-tail in its open conformation, increased
the basal CK1a binding (Figure 7B, lanes 3–6; Figure 7C).
However, the SA0–5 and SD0–5 mutations in the context of Smo
C-tail (SmoCT-SA and SmoCT-SD) did not significantly alter
CK1a binding (Figure 7F), unlike their effect in the context of fulllength Smo. Thus, instead of directly altering the CK1a binding
site, phosphorylation may regulate CK1a binding by influencing
the conformation of Smo C-tail and thus controlling the
accessibility of the CK1a binding pocket. In contrast, the SD0–5
mutation dramatically increased GRK2 binding in the context of
both SmoCT and full-length (Figure 7B and 7F), suggesting that
phosphorylation may increase the affinity of a GRK2 binding
site(s) in the Smo C-tail.
Although kinase binding to Smo is influenced by phosphorylation, we found that Shh still enhanced the binding of CK1a to
SmoSA0–5 and SmoSD0–5 (Figure 7B, lanes 3–6; Figure 7C).
Furthermore, CK1a binding to SmoDC588, which lacks all the
CK1/GRK phosphorylate sites, was also upregulated by Shh
(Figure 7G, compare lanes 5 and 6; Figure S5). These results
demonstrate that Shh can stimulate CK1a binding through a
phosphorylation-independent mechanism. In contrast, GRK2
binding to SmoSD0–5 or SmoSA0–5 was no longer regulated
by Shh (Figure 7B, lanes 3–6), suggesting that Shh promotes
GRK2 binding mainly through the phosphorylation-dependent
mechanism. Taken together, these data suggest that Shh may
regulate CK1a/GRK2 binding in two steps: 1) Shh stimulates
CK1a binding to Smo prior to its phosphorylation, which may
provide a mechanism to initiate Smo phosphorylation, and 2)
phosphorylation of Smo C-tail releases its inhibition on CK1a
binding and at the same time increases its binding affinity for
GRK2, leading to amplification of Smo phosphorylation
(Figure 7J).

mutations (A1 and M1) and three loss-of-function mutations in or
near the CK1a binding pocket identified by previous studies
(Figure 7A) [28,39]. We found that both A1 and M1 resulted in a
constitutive CK1a/GRK2 binding and Smo phosphorylation with
A1 being more potent than M1 (Figure 7H, lanes 3 and 5; Figure
S5). In addition, Shh further increased the binding of CK1a to
and phosphorylation of SmoM1 but not SmoA1 (Figure 7H, lanes
4 and 6; Figure S5). In contrast, the loss-of-function mutations
L430A and S570A blocked Shh-induced CK1a/GRK2 binding
and Smo phosphorylation (Figure 7H, lanes 7–10; Figure S5).
Another loss-of-function mutation, I573A, which mainly affected
Smo stability [28], slightly reduced Shh-stimulated CK1a binding
and Smo phosphorylation (Figure 7H, lanes 11–12; Figure S5).
If L430A and S570A affect Smo phosphorylation because they
interfere with the accessibility of Smo to its kinases, one would
expect that increasing the levels of Smo kinases might rescue the
phosphorylation defect. Indeed, cotransfection of CK1a with
SmoL430A or SmoS570A resulted in their efficient phosphorylation (Figure 7I).
Finally, we found that A1 mimicked Shh stimulation to
enhanced CK1a binding to SmoD588 (Figure 7G, compare lanes
7–8 with 5–6; Figure S5), whereas L430A blocked both the basal
and Shh-stimulated binding of CK1a to SmoD588 (Figure 7G,
lanes 11–12, Figure S5), suggesting that these mutations affect the
phosphorylation-independent mechanism that regulates CK1a
binding (Figure 7J). It is possible that the third intracellular loop
may also contribute to CK1a binding and this is disrupted by
L430A.
In contrast, the M1 and S570 mutations did not affect either the
basal or Shh-stimulated binding of CK1a to SmoD588 (Figure 7G,
lanes 9–10 and 13–14; Figure S5). Thus, M1 and S570 affect
CK1a binding only in the context of full-length Smo and may act
mainly by regulating the release of C-tail inhibition (Figure 7J).

Discussion
Smo is a central component of the Hh signal transduction
cascade and an important cancer drug target, but the molecular
mechanism by which Smo is activated has remained poorly
understood. In this study, we demonstrate that Smo is activated by
multi-site phosphorylation mediated by CK1a and GRK2, and
phosphorylation promotes both ciliary localization and active
conformation of Smo. We provide evidence that graded Shh
signals induce increasing levels of Smo phosphorylation that finetune Smo activity. In addition, we demonstrate that oncogenic
mutations and small molecule Hh pathway modulators including
SAG, oxysterols, and cyclopamine regulate Smo through CK1a/
GRK2-mediated phosphorylation. We provide evidence that Shh
promotes Smo phosphorylation by regulating its accessibility to
CK1a/GRK2 and effective Smo phosphorylation depends on the
primary cilium. The CK1a/GRK2 sites we identified are
conserved among vertebrate Smo proteins; thus, the mechanism
we uncover here is likely to be conserved in other vertebrate
species.

CK1a and GRK2 Regulate Smo Through Multi-Site
Phosphorylation
It has been well established that Drosophila Smo is hyperphosphorylated by multiple kinases in response to Hh stimulation
[22,23,25–27]; however, sequence divergence between Drosophila
and vertebrate Smo proteins makes it unclear whether vertebrate
Smo proteins are similarly phosphorylated in response to Hh.
Using the phospho-tag gel and a phospho-specific antibody, we
provide the first evidence that Shh induces hyperphosphorylation

Regulation of CK1a Binding and Smo Phosphorylation by
Gain- or Loss-of-Function Smo Mutations
To establish the relationship between kinase association and
Smo phosphorylation, we examined how gain- or loss-of-function
Smo mutations affect CK1a binding, including two oncogenic
PLoS Biology | www.plosbiology.org
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In the absence of Hh, Smo may move in and out of the primary
cilium with the exit rate far exceeding the entry rate, resulting in a
low steady state level of Smo in the primary cilium. However, Hhinduced Smo phosphorylation and conformational change could
tilt the balance by increasing the entry rate and/or decreasing the
exit rate. In support of this model, we found that Hh-induced
phosphorylation promoted the binding of b-arr2 to Smo. A recent
study demonstrated that b-arrestins mediate the interaction
between Smo and the anterior-grade trafficking motor kinesin-II
[43]. Thus, Hh-induced phosphorylation may promote Smo
ciliary accumulation by facilitating its anterior grade trafficking
through recruiting b-arr2. It is also possible that phosphorylation
may impede the retrograde trafficking of Smo or may stabilize
Smo protein in the primary cilium.

of Smo, which is mediated by CK1a and GRK2. Several lines of
evidence suggest that CK1a and GRK2 are bona fide Smo
kinases. First, our in vitro kinase assay with purified Smo
fragments and recombinant kinases demonstrated that both
CK1 and GRK phosphorylate multiple sites in Smo C-tail.
Second, mutating the CK1/GRK sites in the Smo C-tail abolished
Shh-stimulated Smo phosphorylation in vivo. Third, using a
phospho-specific antibody that recognized an overlapping CK1/
GRK site (S1), we demonstrated that Shh induced phosphorylation at this site through CK1a and GRK2.
We identified a total of six CK1a/GRK2 phosphorylation
regions, which we named S0 to S5. S0 and S1 contain multiple
phospho-acceptor Ser/Thr residues. Our functional study suggests
that S0 and S1 play a major role while other sites play a finetuning role in Smo regulation. The employment of multi-site
phosphorylation may allow graded Hh morphogens to induce
different levels of Smo activity through differential phosphorylation. Indeed, we found that increasing levels of Shh induced a
progressive increase in the level of Smo phosphorylation.
Furthermore, increasing the number of SA mutations gradually
decreased the level of Shh-induced Smo activity, whereas
increasing the number of phospho-mimetic mutations progressively increased the level of basal Smo activity.
Although phospho-mimetic mutations increase the basal activity
of Smo both in vitro and in vivo, they do not confer full activation
of Smo, which is in contrast to the A1/M2 oncogenic mutation.
One possibility is that the SD mutations may not fully mimic
phosphorylation and may even lock Smo in a less optimal
conformation for activation. However, we think this is unlikely
because the SmoSD variants can be further stimulated by Shh to
reach their full activity. In addition, phospho-mimetic mutations
did not affect SmoA1 activity (unpublished data). These
observations suggest that Shh and A1/M2 may stimulate an
additional mechanism(s) that acts in conjunction with CK1a/
GRK2-mediated phosphorylation to fully activate Smo. The
proposed paralleled mechanisms could be phosphorylationindependent and/or could involve additional kinase(s). Furthermore, although our in vitro and in vivo assays suggest that
phosphorylation at S0–S5 is mediated by CK1a/GRK2, we
cannot rule out the possibility that some of these sites might also be
phosphorylated by other kinases.

Regulation of Smo Phosphorylation
Our data suggested that Shh stimulates Smo phosphorylation,
at least in part by regulating the accessibility of Smo to its kinases.
Our deletion analyses revealed that CK1a and GRK2 bind Smo
through the membrane proximal and distal regions of Smo C-tail,
respectively. We provided evidence that Smo C-tail in its closed
conformation inhibits CK1a binding likely by masking the
membrane proximal CK1a binding pocket through steric
hindrance, and this inhibition is released by phosphorylation that
promotes the open conformation of Smo C-tail. Furthermore, we
demonstrate that Shh stimulates the binding of CK1a to the
membrane proximal region of Smo C-tail through a mechanism
that parallels with the phosphorylation-dependent mechanism. We
propose a two-step mechanism for Shh-regulated kinase association and Smo phosphorylation (Figure 7J). In the first step (referred
to as the initiation step), Shh stimulates CK1a binding to Smo
prior to its phosphorylation, likely by inducing a local conformational change near the membrane proximal region that either
optimizes the CK1a binding pocket or makes it more accessible to
CK1a. This step may contribute to the initiation of Smo
phosphorylation and is promoted by the A1 mutation but is
blocked by the L430A mutation. In the second step (referred to as
the amplification step), CK1a-initiated phosphorylation further
increases CK1a binding by promoting the open conformation of
Smo C-tail. Furthermore, phosphorylation of Smo C-tail increases
its binding affinity for GKR2. Increased binding of CK1a/GRK2
forms a feedback loop to further increase the level of Smo
phosphorylation.
There could be a basal association of CK1a/GRK2 with Smo
in quiescent cells, and Shh could induce a change in Smo that
makes the CK1/GRK sites more accessible to the bound kinases,
which may also contribute to the initiation of Smo phosphorylation. Finally, Smo phosphorylation is likely to be counteracted by a
phosphatase(s), which could be essential for keeping basal Smo
phosphorylation low. Therefore, Shh could regulate the activity or
accessibility of a Smo phosphatase(s) in addition to regulating the
Smo kinases.
Our time course study revealed that phosphorylation of Smo
occurred more rapidly in the primary cilia compared with the
whole cell (Figure 6). In addition, expression of a dominant
negative form of Kif3b, which blocks ciliogenesis, attenuated Shhor A1-induced Smo phosphorylation. These observations suggest
that Smo phosphorylation occurs more efficiently in the primary
cilia. Interestingly, we found that CK1a is accumulated in primary
cilia in response to Shh stimulation (Figure 7D). The increase in
the local concentration of CK1a may explain, at least in part, why
phosphorylation of Smo is more effective in the primary cilium. It
is also possible that Shh-mediated inhibition of Ptc is more
effective in the primary cilium.

Smo Phosphorylation, Conformational Switch, and Ciliary
Localization
A prevalent view regarding Smo activation is that Hh activates
Smo by inducing its ciliary localization [16,17]. However, this
view has been challenged by more recent studies showing that the
Smo inhibitor cyclopamine promotes instead of blocks ciliary
localization of Smo [18,19,45], suggesting that ciliary localization
of Smo is insufficient for its activation. Our previous and current
studies demonstrate that Shh induces a conformational switch in
Smo that is also induced by the A1 mutation and SAG but is
blocked by Smo inhibitors including cyclopamine [22,46,47],
suggesting that Hh-induced Smo conformational switch may
represent an additional step for Smo activation. How Smo
conformational switch and ciliary localization are regulated
remained unknown. Here we demonstrate that both events are
governed by CK1a/GRK2-mediated phosphorylation of Smo Ctail. CK1a/GRK2 phosphorylation-deficient forms of Smo are
locked in a closed conformation and fail to accumulate in primary
cilia in response to Shh stimulation, whereas phospho-mimetic
forms adopt an open conformation and accumulate in the primary
cilia independent of Shh.
PLoS Biology | www.plosbiology.org
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Parallels Between Mammalian and Drosophila Smo
Activation

Materials and Methods

Despite the profound difference in the primary sequence
between Drosophila and vertebrate Smo, our study suggests that
their activation mechanisms are remarkably similar (Figure 8). In
both cases, Hh induces Smo phosphorylation at multiple sites
(although by distinct sets of kinases) that fine-tune Smo activity,
and phosphorylation activates Smo by inducing its active
conformation and regulating its subcellular localization (cell
surface accumulation for dSmo and ciliary accumulation for
mSmo). Hh-stimulated phosphorylation induces dSmo conformation change by antagonizing multiple Arg clusters in its C-tail [22].
As the inactive conformation of mSmo is also maintained by a long
stretch of basic cluster in its C-tail [22], multisite phosphorylation
may promote mSmo conformational change through a similar
mechanism. A recent study has demonstrated that GRK2
regulates dSmo by both kinase-dependent and kinase-independent
mechanisms [48]. The observation that Shh induces mSmo/
GRK2 complex formation raises an interesting possibility that
GRK2 may also function as a molecular scaffold to promote
mSmo activation.

pGE-Smo-CFPC, pGE-Smo-YFPC, and pGE-Smo-CFPL2YFPC
have been described previously [22]. SmoSA and SmoSD
substitutions were generated by site-directed PCR mutagenesis.
To generate GST-Smo fusion constructs, DNA fragments
encoding Smo C-terminal regions with wild type or mutated
phosphorylation sites were amplified by PCR and inserted
between SalI and NotI sites of the pGEX-4T-3 vector. To construct
XZ201-Smo-CFP retrovirus, Smo-CFP variants were PCR out
and subcloned between HpaI and SalI sites in the MSCV retroviral
vector (XZ201, gift from Dr. Alec Zhang’s lab in UTSW). The
bovine source of kinase-expressing constructs used in the shRNA
rescue experiments were generated by PCR amplification and
cloned into pCDNA3.1(+) vector, the dominant negative form of
bovine GRK2 (bGRK2-K220R) was generated by site-directed
PCR mutagenesis strategy, and the pCS2(+)-CK1a and pCS2(+)DN-CK1a are gifts from John Graff’s Lab [49]. LMP/shRNA
against kinase: CK1a, GRK2, or GRK5 were constructed by
inserting indicated shRNA fragments into LMP vector (Open
Biosystems) containing a PGK-puromycin resistance-IRES-GFP

Constructs

Figure 8. A unified mechanism for Smo activation in different species. Multi-site phosphorylation by distinct but overlapping sets of kinases
activates mSmo and dSmo by regulating their subcellular localization and conformation. See text for details.
doi:10.1371/journal.pbio.1001083.g008

PLoS Biology | www.plosbiology.org

13

June 2011 | Volume 9 | Issue 6 | e1001083

Mechanism of Smoothened Activation

cassette. To generate HA-tagged wild type, SA0–5 or SD0–5
versions of Smo C-tail, wild type, or mutant DNA fragments were
amplified by PCR and inserted between NotI and XbaI sites in the
HA-pUAST vectors [50], and the HA-tagged constructs were
subcloned into pCDNA3.1(+) vector with EcoRI and XbaI sites. All
the constructs were sequence verified. DN-Kif3b constructs were
kindly provided by Dr. Pao-Tien Chuang [44].

IgG HRP (1:10,000), and Goat anti-rabbit IgG HRP (1:10,000).
PS1 antibody was generated by Genemed Synthesis Inc.,
phosphorylated peptide EP(pS)ADV(pSpS)AWAQHVTC was
injected into rabbit, the serum was affinity-purified by antigen,
and the flow-through from the affinity-purification was also kept as
control antibody S1 against non-phosphorylated peptide. For
immunofluorescence, cells were seeded on ploy-D Lysine coated
LAB-TEK chamber slides and were transfected with indicated
constructs, followed by treating with indicated reagents for
indicated time. Cells were washed 2 times with 1XPBS and fixed
with 4% PFA, permeabilized, stained, and mounted for observation with Zeiss LSM510 confocal microscope. FRET assays were
performed essentially as previously described [22]. Briefly, CFP
was exited at 458 nM wavelength and YFP at 514 nM
wavelength. CFP signals were collected once before photobleaching (BP) and once after photobleaching (AP) of YFP. YFP was
photobleached with full power of the 514 nM laser line for
1,2 min at the top half of the cells, leaving the bottom half as an
internal control. The CFP signals from the bleached half (both
membrane and cytoplasmic signals) were used for FRET
calculating, and the efficiency of FRET was calculated with the
formula: FRET% = [(CFPAP 2 CFPBP)/CFPAP] 6100.

In Vitro Kinase Assay
CK1/GRK in vitro kinase assay was performed according to
the manufacturer’s instruction (Upstate Biotechnologies, 14-714).
Briefly, GST-fusion proteins, 0.1 mM ATP containing 10 mCi of
c-32p-ATP and kinases: CK1d (New England Biolabs), GRK5
(Upstate Biotechnologies, 14-714), were mixed well and incubated
at 30uC for 1.5 h in reaction buffer (20 mM Tris-HCl, pH 8.0,
2 mM EDTA, 10 mM MgCl2, 1 mM DTT); the reactions were
stopped by adding 46SDS loading buffer and boiled at 100uC for
5 min; and the phosphorylation of GST-fusion proteins were
analyzed by autoradiography after SDS-PAGE.

Cell Cultures
Unless otherwise noted, all the mammalian cell lines were
cultured in DMEM, supplemented with 10% fetal bovine serum
(FBS), L-glutamine, 1 mM sodium pyruvate, and penicillin. NIH
3T3 cells were obtained from ATCC. smo2/2 and Kif3a2/2 mouse
embryonic fibroblasts were kindly provided by Dr. Pao-Tien
Chuang [44]. Wild type MEFs were derived from wild type mice
embryos at 9.5 dpc, embryos were dissected to pieces and
transferred to 10 cm dishes for adherence, regular DMEM
medium were slowly added, fibroblasts cells that migrated from
the embryos were collected by trypsinization after 3,5 d, and
expanded wild-type MEFs were aliquot and frozen for further use.
Reagents were used in the following concentrations unless
otherwise noted: Recombinant Mouse Sonic Hedgehog Nterminus (ShhNp, R&D systems, Cat #464-SH), 293-Shhconditioned medium (1:6 v/v; [40]), SAG (200 nM), cyclopamine
(1 mM), CKI-7 (10 mM; Sigma), and Heparin (1 mM; Sigma). SAG
and cyclopamine are gifts from Dr. James Chen at Stanford
University. The kinase inhibitors were added into the medium the
night before collecting the samples, and for heparin treatment,
5 mg/ml Lipofectin (Invitrogen) were mixed together with the
medium to facilitate their entry into the cells.

8XGliBS-Luciferase Assay
The day before transfection, different cell lines were seeded at a
density of 1,26105 cells/ml in 24-well plates, and cells were
transfected with 8XGliBS-luciferase and pRL-TK at 4:1 ratio, and
5% w/w of pGE-Smo constructs with Fugene 6 (Roche) according
to the manufacturer’s instructions. After 2 d of transfection, cells
were changed to low serum medium (DMEM supplemented with
0.5% calf serum) with or without Shh-conditioned medium
combined with additional treatments as indicated, and cells were
harvested and luciferase activities were determined using the Dual
Luciferase Reporter Assay System (Promega) and FLUOstar
OPTIMA (BMGLABTCH). Each sample was performed in
triplicate and the assays were repeated for at least 3 times.

Chick In Ovo Electroporation
All constructs were electroporated into the neural tube of HH
st11–12 chick embryos [52]. Embryos were harvested 48 h after
electroporation, fixed, and processed for immunohistochemistry as
previously described [53]. The following antibodies were used:
mouse Pax7, Nkx6.1, Nkx2.2 (from DSHB), rabbit Olig2
(Chemicon), rabbit Islet1/2 (a gift from Dr. T. Jessell), and GFP
(Biogenesis). Anterior thoracic levels were analyzed in all cases.

Transfection, Immunoprecipitation, Western Blot,
Immunochemistry, and FRET
For protein expression, cells were transfected with FuGENE 6
transfection reagent (Roche) according to the manufacturer’s
instructions, harvested and lysed in RIPA buffer (50 mM Tris-Cl
at pH 7.9, 150 mM NaCl, 5 mM EDTA), 1% NP-40 supplemented with protease inhibitors (Roche), and lysates were frozen
and thaw 2,3 times. Immunoprecipitation experiments were
performed as previously described [51]. The Phos tag-conjugated
SDS-PAGE analysis was performed according to the standard
protocols [34]. Phos tag-conjugated acrylamide was purchased
from the NARD Institute in Japan. First and secondary antibodies
used in this study: mouse anti-Myc (1:5,000; Sigma), rabbit antiMyc (A-14; Santa Cruz Biotechnologies), mouse anti-HA
(1:10,000; Santa Cruz Biotechnologies), mouse anti-Flag
(1:10,000; Santa Cruz Biotechnologies), rabbit anti-CK1a (Santa
Cruz Biotechnologies), rabbit anti-GRK2 (Santa Cruz Biotechnologies), rabbit anti-GRK5 (Santa Cruz Biotechnologies), rabbit
phospho-specific antibodies against S1 (PS1, 1:50), monoclonal
anti-Acetylated tubulin (1:1,000; Sigam#T7451), Goat anti-mouse
PLoS Biology | www.plosbiology.org

Retroviral Infection and shRNA
Stable NIH 3T3/shRNA cell lines against kinase CK1a,
GRK2, or GRK5 were generated by retroviral infection and
selected with 3 mg/ml of puromycin.
HEK 293T cells were transfected with XZ201 retrovirus vectors
encoding variant Smo cDNAs and pCL-Eco packaging vector,
and supernatants were collected 72 h post-transfection, filtered
through a 0.45 mM syringe filter, and added to 50,70% confluent
wild type MEFs with 8 mg/ml polybrene (Sigma) overnight.

Supporting Information
Figure S1 CK1a and GRK2 regulate Smo phosphorylation and
Shh signaling activity. (A) Diagrams showing the sequences of the
corresponding shRNAs targeting CK1a, GRK2, or GRK5. (B)
Knockdown efficiency by the indicated shRNAs. (Top) Cell extracts
were prepared from NIH3T3 cells with integrated LMP control
vector (CT) or vectors expressing shRNA against different regions of
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Figure S3 Mutating CK1/GRK sites affect Smo activity in chick
neural tube. (A) Activity of Smo SD variants in chick neural tube.
SmoWT, SmoSD1, SmoSD12, SmoSD123, SmoSD1–5, or
SmoSD0–5 were transfected by in ovo electroporation into the
thoracic region of HH st11–12 chick neural tube and the expression
patterns of the indicated markers analyzed 48 h later. In embryos
transfected with SmoSD123, SmoSD1–5, or SmoSD0–5, the
expression of Pax7 was repressed and expression of Isl1, Olig2,
and Nkx2.2 expanded dorsally (arrows). By contrast, the expression
patterns of the neural tube markers in SmoSD1 or SmoSD12
electroporated embryos were similar to those in embryos transfected
with SmoWT. (B) Mutating S1 affects SmoA1 activity in chick
neural tube. SmoA1 or SmoA1 with different combination of SA
mutations (A1SA1, A1SA12, A1SA13, A1SA23, and A1SA123)
were transfected by in ovo electroporation into the thoracic region
of the neural tube of HH st11–12 chick embryos and the expression
patterns of the indicated markers analyzed 48 h later. SmoA1
exhibited constitutive signaling activity, resulting in the dorsal
expansion of ventral markers, including Islet1, Nkx6.1, Olig2, and
Nkx2.2 and the repression of Pax7 (Brackets). Mutating S1 alone
(A1SA1) or in combination with other sites (A1SA12, A1SA13, or
A1SA123) markedly reduced the signaling activity of SmoA1 and
these constructs only induced mild ectopic expression of ventral
markers (arrows). By contrast, mutating S2 and S3 (A1SA23) did not
significantly affect SmoA1 activity.
(TIF)

CK1a, GRK2, or GRK5 and immunoblotted with CK1a, GRK2,
GRK5, and GAPDH antibodies. Representative western blots were
repeated 3 to 5 times. The intensity of each band was analyzed using
the ImageJ software. The numbers indicated percentage of
knockdown. (Bottom) Knockdown efficiency of individual stable
NIH 3T3/shRNA lines measured by real-time PCR. (C–E) Stable
NIH 3T3/shRNA lines were transfected with Smo and WT or
dominant-negative (DN) bovine CK1a (bCK1a) or GRK2
(bGRK2) together with the 8XGliBS-luc reporter and control pRLTK construct, and treated with or without Shh-conditioned
medium, followed by dual Luciferase assay. (F) Cell extracts from
stable NIH 3T3/shRNA cell lines or control NIH 3T3 cells
transfected with Smo-Myc and treated with or without Shhconditioned medium were separated on Phos tag-conjugated SDSPAGE gel and probed with Myc antibody. (G) Gli-luciferase assay in
NIH 3T3 cells in response to Shh stimulation or kinase
overexpression. (H) Gli-luciferase assay in control or CK1a/GRK2
shRNA expressing NIH 3T3 cells treated with or without Shhconditioned medium.
(TIF)
Figure S2 CK1 and GRK phosphorylate multiple sites in Smo.

(A–C) CK1 and GRK phosphorylate individual serine in the S1 site.
(A) A schematic drawing full-length Smo with the sequences for S1,
S2, and S3 indicated underneath. Amino acid substitutions for
individual constructs are indicated. (B–C) In vitro kinase assay using
recombinant CK1d (B) or GRK5 (C) and purified GST-Smo608–
670 fusion proteins with wild type (WT) sequence or indicated
substitutions. (D–E) CK1/GRK sites in Smo C-tail mediate Smo
activation by Shh, CKIa, GRK2, and GRK5. (D) Gli-luc assay in
NIH 3T3 cells transfected with Smo or SmoSA0–5 with or without
the indicated kinase expressing constructs and treated with or
without Shh-conditioned medium. (E) FRET analysis in NIH 3T3
cells transfected with Smo-CFPC/YFPC or SmoSA0–5-CFPC/YFPC
with or without the indicated kinase expressing constructs and
treated with or without Shh-conditioned medium (mean 6 s.d.,
n$10). (F) Evaluation of the specificity of the PS1 antibody. (Top) A
schematic drawing of full-length Smo with the antigen peptide
sequence for generating the PS1 antibody indicated. (Bottom)
Western blot analysis using the PS1 antibody or antibodies against
the non-phosphorylated peptide (S1). The PS1 antibody recognized
GST-Smo608–670 but not GST-Smo608–670SA phosphorylated
by GRK or CK1. In addition, the PS1 antibody did not recognize
the unphosphorylated GST-Smo608–670. Equal amounts of GST
fusion proteins were loaded as indicated by western blot with the S1
antibody. (G) Knockdown of CK1a or GRK2 affected Shh-induced
Smo phosphorylation. Cell extracts from indicated stable NIH 3T3/
shRNA lines transfected with Smo-Myc and treated with or without
Shh-conditioned medium were separated on SDS-PAGE gel and
immunoblotted with PS1 and Myc antibodies. Knockdown of CK1a
or GRK2 but not GRK5 reduced Shh-induced Smo phosphorylation at S1 site. (H–I) The effect of mutating CK1/GRK sites on A1induced Smo phosphorylation and Smo activity in response to Shh
and small molecules. (H) Cell extracts from NIH 3T3 cells
transfected with Smo-Myc, SmoA1-Myc, or SmoA1SA1–5-Myc
and treated with or without Shh-conditioned medium were
separated on Phos tag-conjugated SDS-PAGE gel and immunoblotted with a Myc antibody. Mutating multiple CK1/GRK sites
abolished Shh- or A1-induced mobility shift of the Myc-tagged Smo.
(I) Gli-luc assay in NIH 3T3 cells transfected with Smo, SmoSA0–5,
or SmoSD0–5 and treated with or without the indicated reagents.
The activity of SmoSA0–5 was no longer induced by Shh or SAG,
whereas SmoSD0–5 exhibited elevated basal activity and was more
resistant to cyclopamine (CYC) inhibition.
(TIF)
PLoS Biology | www.plosbiology.org

Figure S4 Primary cilium and Smo phosphorylation. (A)
Quantification of Smo-CFP or PS1 positive cilia in NIH
3T3Smo-CFP treated with different reagents. NIH 3T3Smo-CFP cells
were either untreated or treated with Shh-conditioned medium
(Shh), SAG (200 nM), 20-OHC (10 mM), CYC (10 mM), or a
combination of Shh and CYC (10 mM), SAG (200 nM) and CYC
(10 mM), or 20-OHC (10 mM) and CYC (10 mM). The histogram
indicates the percentage of Smo-CFP or PS1 positive cilia. Over
100 ciliated cells were counted for each time point (n = 3). (B)
FRET analysis in wild type or Kif3a2/2 MEFs transfected with
Smo-CFPC/YFPC, SmoA1-CFPC/YFPC, or SmoSD0–5-CFPC/
YFPC and treated with or without Shh-conditioned medium
(mean 6 s.d., n$10). (C) Gli-luc assay in Kif3a2/2 MEFs
transfected with the indicated constructs and treated with or
without Shh-conditioned medium.
(TIF)
Figure S5 Quantification of CK1a binding to different forms of
Smo. Histograms for the western blot analyses shown in Figure 7G
and Figure 7H. The pull-downed CK1a signal intensity in each
lane was normalized by the pull-downed Smo signal intensity and
compared with lane 1. *p,0.05, **p,0.01, ***p,0.005. The
signal intensity for each band was quantified by ImageJ software
followed by Prism analysis, n = 3.
(TIF)
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